Jim Cramer Believes Competition Could Weaken Intuitive Surgical

Jim Cramer’s comments on Intuitive Surgical may have a modestly positive effect on the competitive landscape. However, SYK’s share price is trading just below its 20‑day simple moving average (SMA20) and also below its 50‑day SMA (SMA50). The relative strength index (RSI) stands at 43.7, and the MACD line is above its signal line, yet a clear short‑term direction remains uncertain. Overall, the market impact is likely to stay limited.

Jim Cramer’s caution that intensified competition could erode Intuitive Surgical’s position may generate short‑term selling pressure. However, technical indicators suggest a short‑term upside potential: the MACD is above its signal line, the price sits above the 20‑period simple moving average (SMA20) and just below the 50‑period SMA (SMA50). The relative strength index (RSI) is at 48, well outside overbought or oversold territory, adding to market uncertainty. Analysts anticipate a modest pullback within the next one to three days, but no major trend reversal is expected. Consequently, the market impact is likely to be neutral or slightly bearish.

Jim Cramer’s concerns about Intuitive Surgical could keep MDT shares under pressure in the near term. Current technical indicators show the price trading below the 50‑day moving average and the RSI hovering around 40, supporting a modest downward trend. Although the MACD is above its signal line—typically a short‑term recovery signal—the negative news may override that cue. A price range of $77.5 to $78.5 is expected over the next one to three days. Investors are advised to review their positions in light of their risk tolerance.